Atomwise
Everything you need to know about Atomwise — from their $219M in funding to who's backing them.
Awaira Score
Out of 100
HQ
United States
Founded
2012
Raised
$219M
Stage
Series B
Team
75
About Atomwise
Atomwise is an artificial intelligence company focused on drug discovery and development, founded in 2012 and headquartered in the United States. The company uses AI and computational chemistry to identify and optimize potential drug candidates, reducing the time and cost associated with traditional pharmaceutical research methods. Atomwise's platform applies machine learning algorithms to screen…
Key Facts
- Atomwise has raised a total of $219M in disclosed funding across 3 funding rounds.
- Atomwise was founded in 2012 by Abraham Heifets and is headquartered in United States.
- Atomwise employs approximately 75 people.
- Atomwise operates in the AI Healthcare category and is currently at the Series B stage.
- Atomwise has an Awaira Score of 53/100, ranking it among the tracked AI companies on Awaira.
- Atomwise's most recent funding round was a Series B of $123M closed in August 2020, led by Temasek.
Source: Awaira · Updated Mar 24, 2026
Valuation
N/A
Post-money
Total Raised
$219M
All rounds
Awaira Score
53/100
Founded
2012
75 employees
Strengths & Risks
Strengths
Established market presence (founded 2012)
Based in the US, the world's largest AI market
Considerations
Valuation not publicly disclosed
Analysis based on publicly available data. Not investment advice.
Funding Velocity
3
Total Rounds
$84M
Avg Round Size
8.8yr
Funding Span
Atomwise raised 3 rounds over 8.8 years, averaging $84M per round — a pace of roughly one round every 35 months.
Awaira estimate based on public data. Not financial advice.
How does Atomwise stack up against competitors?
Competitor Comparison
| Metric | ★Atomwise | Butterfly Network | Tempus | Alan |
|---|---|---|---|---|
| Awaira Score | 53/100 | 85/100 | 84/100 | 83/100 |
| Total Raised | $219M | $370M | $1.05B | $750M |
| Valuation | N/A | $957M | $8.1B | $5.83B |
| Stage | Series B | Public | Public | Series D |
| Founded | 2012 | 2011 | 2015 | 2016 |
| Employees | 75 | 500-1000 | 2500 | 500-1000 |
| Country | 🇺🇸 | 🇺🇸 | 🇺🇸 | 🇫🇷 |
Investors in Atomwise
Funding Rounds
InactiveLed by Temasek
$123M
Aug 2020
Led by Khosla Ventures
$45M
Jan 2015
Undisclosed
Jan 2012
Atomwise Latest News
Atomwise Announces Strategic Partnerships to Scale AI Operations
Atomwise Uses AI to Screen 16 Billion Compounds for New Drug Candidates
Atomwise Expands AI Healthcare Platform to 50 New Countries
Atomwise Reports Strong Growth as AI Industry Accelerates
Atomwise Expands AI Platform with New Enterprise Features and Integrations
Founded Same Year (2012)
Similar by Funding Stage (Series B)
More from United States
🇺🇸 View all AI companies in United States →Alternatives
View all alternatives to Atomwise →If you're looking at Atomwise, also check out
View all AI Healthcare →People Also Viewed
Frequently Asked Questions
What is Atomwise's valuation?▾
Who invested in Atomwise?▾
When did Atomwise last raise funding?▾
How many employees does Atomwise have?▾
What does Atomwise do?▾
Who founded Atomwise?▾
Is Atomwise profitable?▾
Where is Atomwise headquartered?▾
Compare Atomwise
See how Atomwise stacks up against competitors in valuation, funding, team size, and Awaira Score.